WNT5A and breast carcinoma: In breast cancer, WNT5A has been shown to be regulated at the post-transcriptional level via HuR, a member of embryonic lethal abnormal vision (ELAV)-like protein family that binds to evolutionary conserved AU-rich motifs in the untranslated region of its mRNA and suppresses translation [17].